“Cardiovascular disease as a disruptor of systemic homeostasis: implications for underlying host pathologies” – Graeme Koelwyn
Location: Zoom Conference – details below | Time: 12:00 pm – 2:00 pm
Details: Online presentation (1 hour) followed by question period (30 minutes).
Note:
- The presentation will be recorded for those unable to attend the live presentation.
- Please make sure your mic is muted during the presentation.
Topic: CRC Public Health Omics Candidate Presentation
Time: Jul 17, 2020 12:00 PM Pacific Time (US and Canada)
Join Zoom Meeting
https://sfu.zoom.us/j/99983604414?pwd=dnJkRDJaekNWQzNQYVRlU2l3SFYxZz09
Meeting ID: 999 8360 4414
Password: 892140
One tap mobile
+12042727920,,99983604414#,,,,0#,,892140# Canada
+14388097799,,99983604414#,,,,0#,,892140# Canada
Dial by your location
+1 204 272 7920 Canada
+1 438 809 7799 Canada
+1 587 328 1099 Canada
+1 647 374 4685 Canada
+1 647 558 0588 Canada
+1 778 907 2071 Canada
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Germantown)
+1 312 626 6799 US (Chicago)
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
+1 929 205 6099 US (New York)
Meeting ID: 999 8360 4414
Password: 892140
Find your local number: https://sfu.zoom.us/u/acX2ymlzDt
Candidate CV and documents have been shared with you via SFU Vault. To access *Vault, you must sign in with your SFU computing ID. Please consider the CV, documents and recorded presentation as confidential material. *https://www.sfu.ca/itservices/collaboration/sfu-vault.html
Presentation Abstract:
Cardiovascular disease (CVD) events such as myocardial infarction (MI, or heart attack) disrupt systemic homeostasis. Such disruption has important implications for subsequent CVD risk. However, as many patients with MI present with other disease comorbidities, systemic responses to MI may also increase risk for non-CVD pathologies. For example, patients with cancer, particularly those with breast cancer, are at increased risk for CVD due to treatment toxicity and changes in lifestyle behaviors. While elevated risk and incidence of CVD events in breast cancer is well established, whether such events impact cancer pathogenesis is not known. We have identified that CVD events following a breast cancer diagnosis are an independent predictor of recurrence and cancer-specific mortality. In corollary mouse models of breast cancer, MI accelerates tumour growth and metastasis through reprogramming of innate immunity. Mechanistically, MI epigenetically reprograms monocytes in the bone marrow toward an immunosuppressive (pro-tumour) phenotype, which is maintained across the transcriptome in monocytes in the circulation and tumour. In parallel, MI increases circulating monocyte levels and recruitment to tumours, and depletion of these cells abrogates MI-induced tumour growth. Together, these findings demonstrate that MI-induced disruption of systemic homeostasis triggers cross-disease communication that accelerates breast cancer.
Bio:
Dr. Graeme Koelwyn is a postdoctoral fellow at Memorial Sloan Kettering Cancer Center in New York City. He received his B.Sc. (Exercise and Health Physiology) from the University of Calgary, his M.Sc. (Clinical Exercise Physiology) from the University of British Columbia, and his Ph.D. (Pathobiology and Translational Medicine) from New York University.
His research applies a systems biology and ‘omics-based approach to discern the causal pathways that link cardiovascular disease to other host pathologies, including cancer, and how interventions such as exercise can protect from such deleterious interactions. In particular, his research focusses on how cardiovascular disease and exercise can imprint systemic ‘learned’ responses in the innate immune system, altering concurrent and subsequent host responses to disease.
Please send your candidate feedback to the search committee Chair Jeremy Snyder and/or committee at fhs-crcomicssearch@sfu.ca
Committee Members:
Tania Bubela – Chair
Robert Hogg
Zabrina Brumme
Don Sin
Scott Tebbutt
Will Hsiao